Empyrean Capital Partners’s UnitedHealth UNH Stock Holding History

Empyrean Capital Partners’s Portfolio UNH Stock Details UNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-193,000	Closed	-$63.7M	–	136
2025 Q4	$63.7M	Buy	+193,000	New	+$65.4M	2.22%	15
2025 Q3	–	Sell	-94,000	Closed	-$29.3M	–	96
2025 Q2	$29.3M	Sell	94,000 -26,000	-22%	-$9.94M	0.98%	28
2025 Q1	$62.9M	Buy	+120,000	New	+$61.3M	2.23%	12
2015 Q3	–	Sell	-200,000	Closed	-$24.4M	–	63
2015 Q2	$24.4M	Buy	+200,000	New	+$23.7M	1.14%	29
2014 Q4	–	Sell	-1,364,000	Closed	-$118M	–	61
2014 Q3	$118M	Sell	1,364,000 -436,000	-24%	-$36.8M	4.16%	4
2014 Q2	$147M	Buy	1,800,000 +585,000	+48%	+$46M	5.18%	3
2014 Q1	$99.6M	Buy	1,215,000 +865,000	+247%	+$65.1M	3.8%	5
2013 Q4	$26.4M	Buy	+350,000	New	+$25.1M	0.93%	27
2013 Q3	–	Sell	-1,100,000	Closed	-$72M	–	80
2013 Q2	$72M	Buy	+1,100,000	New	+$68.4M	1.67%	18

Other funds holding UNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Empyrean Capital Partners's UNH Position: Q1 2026 in Review

Empyrean Capital Partners sold out of UnitedHealth (UNH) in Q1 2026, closing a stake of 193,000 shares — an estimated $63.7M sold.

Empyrean Capital Partners first reported a position in UNH in Q2 2013 and held it in 9 quarters. The position peaked at $147M in Q2 2014. 3,021 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

Empyrean Capital Partners reported no remaining UnitedHealth position as of Q1 2026 after selling out during the quarter.
Empyrean Capital Partners sold 193,000 UnitedHealth shares in Q1 2026, an estimated $63.7M.
Empyrean Capital Partners first reported a position in UnitedHealth in Q2 2013 and held it in 9 quarters.
Empyrean Capital Partners's UnitedHealth position peaked at $147M in Q2 2014.
3,021 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Empyrean Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.